Landscapes / Targets
androgen receptor
15 drugs act on androgen receptor, in 44 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs15
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Johnson & Johnson (Janssen) · Public JNJ |
Approved | 1 Dec 2026soonPhase 3 trial completes | ||
| Next date | 1 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer and 7 more | ||||
| Open drug page | |||||
Androgen receptor inhibitor |
Pfizer +1 · Public PFE |
Approved | 28 Feb 2027Phase 3 trial completes | ||
| How it works | Blocks the male hormone testosterone from acting on cells | ||||
| Next date | 28 Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Prostate Cancer, Hormone Sensitive Prostate Cancer and 14 more | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Approved in China | Mar 2027Phase 3 trial completes | ||
| Next date | Mar 2027 · Phase 3 trial completes | ||||
| Also tested for | Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | ||||
| Open drug page | |||||
— |
Approved | 30 Jul 2027Phase 3 trial completes | |||
| Next date | 30 Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Cancer, Non-metastatic Castration-resistant Prostate Cancer and 2 more | ||||
| Open drug page | |||||
Androgen receptor inhibitor |
Approved | 7 Aug 2028Phase 3 trial completes | |||
| How it works | Blocks the male hormone testosterone from acting on cells | ||||
| Next date | 7 Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | Acne Vulgaris | ||||
| Open drug page | |||||
— |
Approved in EU, UK | 31 May 2029Phase 3 trial completes | |||
| Next date | 31 May 2029 · Phase 3 trial completes | ||||
| Also tested for | Contraception | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Prostatic Neoplasms, Advanced Prostate Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2027Phase 1/2 trial completes | |||
| Next date | Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic Castration-resistant Prostate Cancer | ||||
| Open drug page | |||||
SARM, muscle preservation |
Veru · Public VERU |
Phase 2 | Oct 2027Phase 2 trial completes | ||
| Next date | Oct 2027 · Phase 2 trial completes | ||||
| Also tested for | Obesity & Overweight, Mobility Disability and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2028Phase 1/2 trial completes | |||
| Next date | Feb 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Jun 2028Phase 1/2 trial completes | |||
| Next date | 1 Jun 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Androgenetic Alopecia | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | — | ||
| Also tested for | Prostate Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Metastatic Castration-resistant Prostate Cancer | ||||
| Open drug page | |||||
— |
Roche · Public ROG.SW |
Phase 1 | 30 Jun 2027Phase 1 trial completes | ||
| Next date | 30 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Prostate Cancer, Metastatic Prostate Cancer | ||||
| Open drug page | |||||
Enolennot checked |
— |
Phase 1 | 30 Dec 2028Phase 1 trial completes | ||
| Next date | 30 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Prostate Adenocarcinoma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 14 of 15 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026